{"id":7947,"date":"2020-09-14T09:15:10","date_gmt":"2020-09-14T09:15:10","guid":{"rendered":"https:\/\/biovegen.org\/?p=7947"},"modified":"2020-09-16T09:55:56","modified_gmt":"2020-09-16T09:55:56","slug":"biovegen-asiste-al-webinario-taller-compitte-ayudas-start-ups-y-pymes-innovadoras","status":"publish","type":"post","link":"https:\/\/biovegen.org\/en\/otros\/biovegen-asiste-al-webinario-taller-compitte-ayudas-start-ups-y-pymes-innovadoras\/","title":{"rendered":"BIOVEGEN attends the Webinar \u201cCOMPITTE Workshop Helps Start-ups and Innovative SMEs\u201d"},"content":{"rendered":"<p>BIOVEGEN participated in the <strong>Webinar \u201cCOMPITTE Workshop Helps Start-ups and Innovative SMEs\u201d<\/strong> which was organized by the Fundaci\u00f3n Universidad Aut\u00f3noma de Madrid (FUAM). The event was dedicated to discussing the characteristics of the call for\u00a0<strong>aid to new technology-based companies and highly innovative SMEs in the Community of Madrid<\/strong> which will mobilize a total of 4,250.00 euros.<\/p>\n\n\n\n<p>Madrid SMEs can access aid of up to 60,000 euros for the creation and start of activities of technology-based companies; up to 125,000 euros for their growth; and up to 250,000 euros for SMEs with high innovative intensity.&nbsp;<\/p>\n\n\n\n<p>The aid is aimed at financing innovative business activities that require the use of technology or knowledge generated by research organizations of the Community of Madrid or the market, and will focus on the thematic areas of the RIS3 of the Community of Madrid. &nbsp;<\/p>","protected":false},"excerpt":{"rendered":"<p>BIOVEGEN particip\u00f3 en el Webinar \u201cTaller COMPITTE Ayudas Start-up&#8217;s y PYMEs innovadoras\u201d que fue organizado por La Fundaci\u00f3n Universidad Aut\u00f3noma de Madrid (FUAM). El evento estuvo dedicado a debatir las caracter\u00edsticas de la convocatoria de\u00a0ayudas a nuevas empresas de base tecnol\u00f3gica y PYMEs altamente innovadoras de la Comunidad de Madrid que movilizar\u00e1n un total de [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":7948,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[1,22,19],"tags":[],"class_list":["post-7947","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-otros","category-actualidad","category-noticias"],"acf":[],"_links":{"self":[{"href":"https:\/\/biovegen.org\/en\/wp-json\/wp\/v2\/posts\/7947","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/biovegen.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/biovegen.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/biovegen.org\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/biovegen.org\/en\/wp-json\/wp\/v2\/comments?post=7947"}],"version-history":[{"count":0,"href":"https:\/\/biovegen.org\/en\/wp-json\/wp\/v2\/posts\/7947\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/biovegen.org\/en\/wp-json\/wp\/v2\/media\/7948"}],"wp:attachment":[{"href":"https:\/\/biovegen.org\/en\/wp-json\/wp\/v2\/media?parent=7947"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/biovegen.org\/en\/wp-json\/wp\/v2\/categories?post=7947"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/biovegen.org\/en\/wp-json\/wp\/v2\/tags?post=7947"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}